ออฟไลน์ด้วยแอป Player FM !
Ep. 255: “Pathway to the Clinic” Featuring Drs. Stefan Irion and Viviane Tabar
ซีรีส์ที่ถูกเก็บถาวร ("ฟีดที่ไม่ได้ใช้งาน" status)
When? This feed was archived on April 03, 2024 18:12 (). Last successful fetch was on February 28, 2024 16:50 ()
Why? ฟีดที่ไม่ได้ใช้งาน status. เซิร์ฟเวอร์ของเราไม่สามารถดึงฟีดพอดคาสท์ที่ใช้งานได้สักระยะหนึ่ง
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 383822524 series 2320644
Guests:
Dr. Stefan Irion is the Chief Scientific Officer of BlueRock Therapeutics and Dr. Viviane Tabar is the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center. In this special episode, recorded in front of a live audience in New York, they talk about their work on BlueRock’s clinical trial for bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease. They also discuss what’s next for cell therapy and diversity in science and in patients.
Featured Products and Resources:
284 ตอน
ซีรีส์ที่ถูกเก็บถาวร ("ฟีดที่ไม่ได้ใช้งาน" status)
When? This feed was archived on April 03, 2024 18:12 (). Last successful fetch was on February 28, 2024 16:50 ()
Why? ฟีดที่ไม่ได้ใช้งาน status. เซิร์ฟเวอร์ของเราไม่สามารถดึงฟีดพอดคาสท์ที่ใช้งานได้สักระยะหนึ่ง
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 383822524 series 2320644
Guests:
Dr. Stefan Irion is the Chief Scientific Officer of BlueRock Therapeutics and Dr. Viviane Tabar is the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center. In this special episode, recorded in front of a live audience in New York, they talk about their work on BlueRock’s clinical trial for bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease. They also discuss what’s next for cell therapy and diversity in science and in patients.
Featured Products and Resources:
284 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ